USPH Intrinsic Value Calculation – Research Analysts Predict Strong Earnings for U.S. Physical Therapy, in FY2025
October 19, 2024

☀️Trending News
U.S. ($NYSE:USPH) Physical Therapy, Inc. is a leading provider of outpatient physical therapy services in the United States. In addition to its clinics, U.S. Physical Therapy also provides management services to third-party clinics and hospitals. The company’s stock has been performing well in recent years, and research analysts are predicting even stronger earnings for the company in fiscal year 2025. This positive outlook is based on several key factors that are expected to drive growth for U.S. Physical Therapy. This presents a significant opportunity for U.S. Physical Therapy to expand its patient base and increase revenues.
Additionally, the company has been implementing strategic initiatives to drive growth and improve efficiency. This includes expanding its network of clinics, investing in new technologies and treatment methods, and pursuing acquisitions of other physical therapy providers. These efforts are expected to have a positive impact on the company’s bottom line in the coming years. Furthermore, U.S. Physical Therapy has a track record of strong financial performance, with consistent revenue and earnings growth over the past few years. This has instilled confidence in research analysts that the company will continue to deliver strong results in the future. Despite potential challenges in the healthcare industry, such as changes in reimbursement policies, U.S. Physical Therapy remains well-positioned for success. With its established market presence, strategic initiatives, and strong financial performance, it is not surprising that research analysts are predicting strong earnings for the company in fiscal year 2025. With a focus on meeting the growing demand for physical therapy services and implementing strategic initiatives, the company is expected to deliver strong earnings in fiscal year 2025. This makes it a promising investment opportunity for those looking to add a reliable and profitable stock to their portfolio.
Earnings
In the recent earning report for FY2023 Q4, U.S. PHYSICAL THERAPY, Inc. has shown strong performance with a total revenue of 129.83M USD and net income of 10.21M USD. This marks a significant increase in net income compared to the previous year, with a growth of 291.2%.
However, there was a slight decrease of 8.0% in total revenue. Despite this decline in revenue, it is important to note that U.S. PHYSICAL THERAPY has consistently shown growth over the past three years. In fact, the company’s total revenue has increased from 129.83M USD to 154.8M USD over this period. This demonstrates the company’s ability to maintain a positive trend in its financial performance and suggests a promising outlook for future earnings. This positive trend in earnings can be attributed to several factors. Firstly, U.S. PHYSICAL THERAPY has a strong presence in the healthcare industry, particularly in the field of physical therapy. With an aging population and increasing demand for healthcare services, the company is well-positioned to capitalize on this growing market.
Additionally, U.S. PHYSICAL THERAPY has also made strategic investments and partnerships to expand its reach and offerings. This includes acquiring new clinics and opening new locations, as well as offering new services and programs to cater to the evolving needs of patients. With such strong performance in recent years and a continued focus on growth and innovation, research analysts are predicting that U.S. PHYSICAL THERAPY will continue to see strong earnings in the upcoming fiscal year of 2025. This is a positive sign for investors and stakeholders, as well as for the company’s overall financial health and stability.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for USPH. More…
| Total Revenues | Net Income | Net Margin |
| 604.8 | 28.24 | 6.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for USPH. More…
| Operations | Investing | Financing |
| 81.98 | -45.02 | 84.27 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for USPH. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 997.24 | 345 | 31.77 |
Key Ratios Snapshot
Some of the financial key ratios for USPH are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 12.7% | 2.0% | 9.7% |
| FCF Margin | ROE | ROA |
| 12.0% | 7.6% | 3.7% |
Price History
This news has caused a surge in the company’s stock, with a 3.57% increase in price from the previous day’s closing price of $77.52. On Friday, the stock opened at $77.52 and closed at $80.29, showing a significant rise in value. This positive movement is attributed to the promising forecast for U.S. Physical Therapy’s future financial performance. One factor that is expected to contribute to the company’s success is its steady growth in the healthcare industry. As the demand for physical therapy services continues to rise, U.S. Physical Therapy is well-positioned to capitalize on this trend. Furthermore, the company has a strong track record of financial stability and profitability, which further supports the predictions of strong earnings in FY2025.
In addition to its financial performance, U.S. Physical Therapy has also been investing in new technologies and expanding its services to meet the evolving needs of its patients. This commitment to innovation and growth is expected to drive future earnings and solidify the company’s position in the market. Overall, the forecast for U.S. Physical Therapy’s financial performance in FY2025 is highly positive, which is reflected in the recent uptick in stock prices. With a strong foundation and a promising outlook, the company is poised for continued success in the years to come. Live Quote…
Analysis – USPH Intrinsic Value Calculation
As an analytical company, GoodWhale has conducted thorough studies on the well-being of U.S. PHYSICAL THERAPY. Our team has analyzed various aspects of the company, including financial performance, market trends, and overall health of the business. Based on our proprietary Valuation Line, we have determined that the fair value of U.S. PHYSICAL THERAPY’s shares is approximately $102.1. This calculation takes into account multiple factors such as growth potential, industry standards, and historical data. Currently, U.S. PHYSICAL THERAPY’s stock is trading at $80.29, which indicates that it is undervalued by 21.4% according to our calculations. This suggests that the stock has potential for growth and presents a buying opportunity for investors. Our analysis also takes into consideration the current market conditions and potential risks that could affect the stock’s value. However, we believe that U.S. PHYSICAL THERAPY has strong fundamentals and is well-positioned in the market, making it a promising investment opportunity. In conclusion, our findings suggest that U.S. PHYSICAL THERAPY’s stock is currently undervalued and has the potential to provide significant returns for investors in the long run. As always, we recommend conducting thorough research and seeking professional advice before making any investment decisions. More…

Peers
The US Physical Therapy Inc is in competition with Extendicare Inc, Optimax Holdings Bhd, Ensign Group Inc. All these companies are in the business of providing physical therapy and related services. US Physical Therapy Inc is the largest of these companies and has the most experience in the industry. However, all the companies are striving to provide the best quality services to their customers.
– Extendicare Inc ($TSX:EXE)
Extendicare Inc. is a Canadian operator of nursing homes and retirement homes. The company has a market cap of 615.07M as of 2022 and a return on equity of 19.21%. Extendicare operates in Canada and the United States, with a total of over 500 facilities. The company’s services include long-term care, post-acute care, and assisted living.
– Optimax Holdings Bhd ($KLSE:0222)
Optimax Holdings Bhd is a Malaysian company that is involved in the provision of optical products and services. The company has a market capitalization of 405 million as of 2022 and a return on equity of 29.84%. The company’s main business activities include the manufacture and sale of optical products, the provision of optical services, and the trading of optical products.
– Ensign Group Inc ($NASDAQ:ENSG)
Ensign Group Inc is a leading provider of healthcare services in the United States. The company has a market cap of 4.77B as of 2022 and a Return on Equity of 19.3%. Ensign Group Inc provides a wide range of healthcare services including skilled nursing, assisted living, home health, hospice, and rehabilitation services. The company has a strong focus on quality and customer satisfaction. Ensign Group Inc is committed to providing the highest quality of care to its patients and families.
Summary
According to research analysts, U.S. Physical Therapy, Inc. is expected to see positive earnings in the fiscal year 2025. This forecast could potentially attract investors who are looking for long-term growth opportunities.
Additionally, on the day that this forecast was released, the company’s stock price increased, indicating positive sentiment from investors. While further research into the company’s background and financials may be necessary before making any investment decisions, these recent developments suggest potential for growth and profitability in the future. As always, it is important for investors to carefully analyze all factors and consult with financial experts before making any investment decisions.
Recent Posts









